Medical Billing Code Search
What is a code?
9012 results found
J3415 | Pyridoxine hcl 100 mg | Description: Injection, pyridoxine hcl, 100 mg |
J3420 | Vitamin b12 injection | Description: Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
J3424 | Inj hydroxocobalamin iv 25mg | Description: Injection, hydroxocobalamin, intravenous, 25 mg |
J3425 | Hydroxocobalamin im 10mcg | Description: Injection, hydroxocobalamin, intramuscular, 10 mcg |
J3430 | Vitamin k phytonadione inj | Description: Injection, phytonadione (vitamin k), per 1 mg |
J3465 | Injection, voriconazole | Description: Injection, voriconazole, 10 mg |
J3470 | Hyaluronidase injection | Description: Injection, hyaluronidase, up to 150 units |
J3471 | Ovine, up to 999 usp units | Description: Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
J3472 | Ovine, 1000 usp units | Description: Injection, hyaluronidase, ovine, preservative free, per 1000 usp units |
J3473 | Hyaluronidase recombinant | Description: Injection, hyaluronidase, recombinant, 1 usp unit |
J3475 | Inj magnesium sulfate | Description: Injection, magnesium sulfate, per 500 mg |
J3480 | Inj potassium chloride | Description: Injection, potassium chloride, per 2 meq |
J3485 | Zidovudine | Description: Injection, zidovudine, 10 mg |
J3486 | Ziprasidone mesylate | Description: Injection, ziprasidone mesylate, 10 mg |
J3489 | Zoledronic acid 1mg | Description: Injection, zoledronic acid, 1 mg |
J3490 | Drugs unclassified injection | Description: Unclassified drugs |
J3520 | Edetate disodium per 150 mg | Description: Edetate disodium, per 150 mg |
J3530 | Nasal vaccine inhalation | Description: Nasal vaccine inhalation |
J3535 | Metered dose inhaler drug | Description: Drug administered through a metered dose inhaler |
J3570 | Laetrile amygdalin vit b17 | Description: Laetrile, amygdalin, vitamin b17 |
J3590 | Unclassified biologics | Description: Unclassified biologics |
J3591 | Esrd on dialysi drug/bio noc | Description: Unclassified drug or biological used for esrd on dialysis |
J7030 | Normal saline solution infus | Description: Infusion, normal saline solution , 1000 cc |
J7040 | Normal saline solution infus | Description: Infusion, normal saline solution, sterile (500 ml = 1 unit) |
J7042 | 5% dextrose/normal saline | Description: 5% dextrose/normal saline (500 ml = 1 unit) |
J7050 | Normal saline solution infus | Description: Infusion, normal saline solution, 250 cc |
J7060 | 5% dextrose/water | Description: 5% dextrose/water (500 ml = 1 unit) |
J7070 | D5w infusion | Description: Infusion, d5w, 1000 cc |
J7100 | Dextran 40 infusion | Description: Infusion, dextran 40, 500 ml |
J7110 | Dextran 75 infusion | Description: Infusion, dextran 75, 500 ml |
J7120 | Ringers lactate infusion | Description: Ringers lactate infusion, up to 1000 cc |
J7121 | 5% dextrose in lac ringers | Description: 5% dextrose in lactated ringers infusion, up to 1000 cc |
J7131 | Hypertonic saline sol | Description: Hypertonic saline solution, 1 ml |
J7165 | Inj, human-lans, per i.u | Description: Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity |
J7168 | Prothrombin complex kcentra | Description: Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity |
J7169 | Inj andexxa, 10 mg | Description: Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg |
J7170 | Inj., emicizumab-kxwh 0.5 mg | Description: Injection, emicizumab-kxwh, 0.5 mg |
J7171 | Inj, adzynma, 10 iu | Description: Injection, adamts13, recombinant-krhn, 10 iu |
J7172 | Inj marstacim-hncq, 0.5 mg | Description: Injection, marstacimab-hncq, 0.5 mg |
J7173 | Inj. concizumab-mtci, 0.5 mg | Description: Injection, concizumab-mtci, 0.5 mg |
J7174 | Injection fitusiran 0.04 mg | Description: Injection, fitusiran, 0.04 mg |
J7175 | Inj, factor x, (human), 1iu | Description: Injection, factor x, (human), 1 i.u. |
J7177 | Inj., fibryga, 1 mg | Description: Injection, human fibrinogen concentrate (fibryga), 1 mg |
J7178 | Inj human fibrinogen con nos | Description: Injection, human fibrinogen concentrate, not otherwise specified, 1 mg |
J7179 | Vonvendi inj 1 iu vwf:rco | Description: Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco |
J7180 | Factor xiii anti-hem factor | Description: Injection, factor xiii (antihemophilic factor, human), 1 i.u. |
J7181 | Factor xiii recomb a-subunit | Description: Injection, factor xiii a-subunit, (recombinant), per iu |
J7182 | Factor viii recomb novoeight | Description: Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu |
J7183 | Wilate injection | Description: Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco |
J7185 | Xyntha inj | Description: Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u. |
J7186 | Antihemophilic viii/vwf comp | Description: Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u. |
J7187 | Humate-p, inj | Description: Injection, von willebrand factor complex (humate-p), per iu vwf:rco |
J7188 | Factor viii recomb obizur | Description: Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u. |
J7189 | Factor viia recomb novoseven | Description: Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram |
J7190 | Factor viii | Description: Factor viii (antihemophilic factor, human) per i.u. |
J7191 | Factor viii (porcine) | Description: Factor viii (antihemophilic factor (porcine)), per i.u. |
J7192 | Factor viii recombinant nos | Description: Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified |
J7193 | Factor ix non-recombinant | Description: Factor ix (antihemophilic factor, purified, non-recombinant) per i.u. |
J7194 | Factor ix complex | Description: Factor ix, complex, per i.u. |
J7195 | Factor ix recombinant nos | Description: Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified |
J7196 | Antithrombin recombinant | Description: Injection, antithrombin recombinant, 50 i.u. |
J7197 | Antithrombin iii injection | Description: Antithrombin iii (human), per i.u. |
J7198 | Anti-inhibitor | Description: Anti-inhibitor, per i.u. |
J7199 | Hemophilia clot factor noc | Description: Hemophilia clotting factor, not otherwise classified |
J7200 | Factor ix recombinan rixubis | Description: Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu |
J7201 | Factor ix alprolix recomb | Description: Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. |
J7202 | Factor ix idelvion inj | Description: Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. |
J7203 | Factor ix recomb gly rebinyn | Description: Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu |
J7204 | Inj recombin esperoct per iu | Description: Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu |
J7205 | Factor viii fc fusion recomb | Description: Injection, factor viii fc fusion protein (recombinant), per iu |
J7207 | Factor viii pegylated recomb | Description: Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. |
J7208 | Inj. jivi 1 iu | Description: Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u. |
J7209 | Factor viii nuwiq recomb 1iu | Description: Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. |
J7210 | Inj, afstyla, 1 i.u. | Description: Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. |
J7211 | Inj, kovaltry, 1 i.u. | Description: Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u. |
J7212 | Factor viia recomb sevenfact | Description: Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram |
J7213 | Inj, ixinity, 1 i.u. | Description: Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. |
J7214 | Altuviiio per factor viii iu | Description: Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u. |
J7294 | Seg acet and eth estr yearly | Description: Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each |
J7295 | Eth estr and eton monthly | Description: Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each |
J7296 | Kyleena, 19.5 mg | Description: Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg |
J7297 | Liletta, 52 mg | Description: Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
J7298 | Mirena, 52 mg | Description: Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
J7300 | Intra copp contra (paragard) | Description: Intrauterine copper contraceptive (paragard) |
J7301 | Skyla, 13.5 mg | Description: Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg |
J7302 | Levonorgestrel iu 52 mg | Description: Levonorgestrel-releasing intrauterine contraceptive system, 52 mg |
J7303 | Contraceptive vaginal ring | Description: Contraceptive supply, hormone containing vaginal ring, each |
J7304 | Contraceptive hormone patch | Description: Contraceptive supply, hormone containing patch, each |
J7306 | Levonorgestrel implant sys | Description: Levonorgestrel (contraceptive) implant system, including implants and supplies |
J7307 | Etonogestrel implant system | Description: Etonogestrel (contraceptive) implant system, including implant and supplies |
J7308 | Aminolevulinic acid hcl top | Description: Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) |
J7309 | Methyl aminolevulinate, top | Description: Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram |
J7310 | Ganciclovir long act implant | Description: Ganciclovir, 4.5 mg, long-acting implant |
J7311 | Inj., retisert, 0.01 mg | Description: Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg |
J7312 | Dexamethasone intra implant | Description: Injection, dexamethasone, intravitreal implant, 0.1 mg |
J7313 | Inj., iluvien, 0.01 mg | Description: Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg |
J7314 | Inj., yutiq, 0.01 mg | Description: Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg |
J7315 | Ophthalmic mitomycin | Description: Mitomycin, ophthalmic, 0.2 mg |
J7316 | Inj, ocriplasmin, 0.125 mg | Description: Injection, ocriplasmin, 0.125 mg |
J7318 | Inj, durolane 1 mg | Description: Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg |
J7320 | Genvisc 850, inj, 1mg | Description: Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
J7321 | Hyalgan supartz visco-3 dose | Description: Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
J7322 | Hymovis injection 1 mg | Description: Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg |
J7323 | Euflexxa inj per dose | Description: Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
J7324 | Orthovisc inj per dose | Description: Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
J7325 | Synvisc or synvisc-one | Description: Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
J7326 | Gel-one | Description: Hyaluronan or derivative, gel-one, for intra-articular injection, per dose |
J7327 | Monovisc inj per dose | Description: Hyaluronan or derivative, monovisc, for intra-articular injection, per dose |
J7328 | Gelsyn-3 injection 0.1 mg | Description: Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg |
J7329 | Inj, trivisc 1 mg | Description: Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg |
J7330 | Cultured chondrocytes implnt | Description: Autologous cultured chondrocytes, implant |
J7331 | Synojoynt, inj., 1 mg | Description: Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg |
J7332 | Inj., triluron, 1 mg | Description: Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg |
J7333 | Visco-3 inj dose | Description: Hyaluronan or derivative, visco-3, for intra-articular injection, per dose |
J7335 | Capsaicin 8% patch | Description: Capsaicin 8% patch, per 10 square centimeters |
J7336 | Capsaicin 8% patch | Description: Capsaicin 8% patch, per square centimeter |
J7340 | Carbidopa levodopa ent 100ml | Description: Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml |
J7342 | Ciprofloxacin otic susp 6 mg | Description: Instillation, ciprofloxacin otic suspension, 6 mg |
J7345 | Aminolevulinic acid, 10% gel | Description: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg |
J7351 | Inj bimatoprost itc imp1mcg | Description: Injection, bimatoprost, intracameral implant, 1 microgram |
J7352 | Afamelanotide implant, 1 mg | Description: Afamelanotide implant, 1 mg |
J7353 | Anacaulase-bcdb 8.8% gel 1 g | Description: Anacaulase-bcdb, 8.8% gel, 1 gram |
J7354 | Cantharidin top, applicator | Description: Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) |
J7355 | Inj travoprost intra impl | Description: Injection, travoprost, intracameral implant, 1 microgram |
J7356 | Inj foscarb/foslevodopa 5 mg | Description: Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg |
J7401 | Mometasone furoate sinus imp | Description: Mometasone furoate sinus implant, 10 micrograms |
J7402 | Mometasone sinus sinuva | Description: Mometasone furoate sinus implant, (sinuva), 10 micrograms |
J7500 | Azathioprine oral 50mg | Description: Azathioprine, oral, 50 mg |
J7501 | Azathioprine parenteral | Description: Azathioprine, parenteral, 100 mg |
J7502 | Cyclosporine oral 100 mg | Description: Cyclosporine, oral, 100 mg |
J7503 | Tacrol envarsus ex rel oral | Description: Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg |
J7504 | Lymphocyte immune globulin | Description: Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg |
J7505 | Monoclonal antibodies | Description: Muromonab-cd3, parenteral, 5 mg |
J7506 | Prednisone oral | Description: Prednisone, oral, per 5 mg |
J7507 | Tacrolimus imme rel oral 1mg | Description: Tacrolimus, immediate release, oral, 1 mg |
J7508 | Tacrol astagraf ex rel oral | Description: Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg |
J7509 | Methylprednisolone oral | Description: Methylprednisolone oral, per 4 mg |
J7510 | Prednisolone oral per 5 mg | Description: Prednisolone oral, per 5 mg |
J7511 | Antithymocyte globuln rabbit | Description: Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg |
J7512 | Prednisone ir or dr oral 1mg | Description: Prednisone, immediate release or delayed release, oral, 1 mg |
J7513 | Daclizumab, parenteral | Description: Daclizumab, parenteral, 25 mg |
J7514 | Mycophenol (myhibbin) 100 mg | Description: Mycophenolate mofetil (myhibbin), oral suspension, 100 mg |
J7515 | Cyclosporine oral 25 mg | Description: Cyclosporine, oral, 25 mg |
J7516 | Inj, cyclosporine 250mg | Description: Injection, cyclosporine, 250 mg |
J7517 | Mycophenolate mofetil oral | Description: Mycophenolate mofetil, oral, 250 mg |
J7518 | Mycophenolic acid | Description: Mycophenolic acid, oral, 180 mg |
J7519 | Inj. mycophenolate mofetil | Description: Injection, mycophenolate mofetil, 10 mg |
J7520 | Sirolimus, oral | Description: Sirolimus, oral, 1 mg |
J7521 | Tacrolim granules oral susp | Description: Tacrolimus, granules, oral suspension, 0.1 mg |
J7525 | Tacrolimus injection | Description: Tacrolimus, parenteral, 5 mg |
J7527 | Oral everolimus | Description: Everolimus, oral, 0.25 mg |
J7599 | Immunosuppressive drug noc | Description: Immunosuppressive drug, not otherwise classified |
J7601 | Ensifentrine inh 3 mg | Description: Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg |
J7604 | Acetylcysteine comp unit | Description: Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram |
J7605 | Arformoterol non-comp unit | Description: Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
J7606 | Formoterol fumarate, inh | Description: Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms |
J7607 | Levalbuterol comp con | Description: Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg |
J7608 | Acetylcysteine non-comp unit | Description: Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram |
J7609 | Albuterol comp unit | Description: Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
J7610 | Albuterol comp con | Description: Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
J7611 | Albuterol non-comp con | Description: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
J7612 | Levalbuterol non-comp con | Description: Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg |
J7613 | Albuterol non-comp unit | Description: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
J7614 | Levalbuterol non-comp unit | Description: Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
J7615 | Levalbuterol comp unit | Description: Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg |
J7620 | Albuterol ipratrop non-comp | Description: Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
J7622 | Beclomethasone comp unit | Description: Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7624 | Betamethasone comp unit | Description: Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7626 | Budesonide non-comp unit | Description: Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
J7627 | Budesonide comp unit | Description: Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg |
J7628 | Bitolterol mesylate comp con | Description: Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7629 | Bitolterol mesylate comp unt | Description: Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7631 | Cromolyn sodium noncomp unit | Description: Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
J7632 | Cromolyn sodium comp unit | Description: Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams |
J7633 | Budesonide non-comp con | Description: Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram |
J7634 | Budesonide comp con | Description: Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram |
J7635 | Atropine comp con | Description: Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7636 | Atropine comp unit | Description: Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7637 | Dexamethasone comp con | Description: Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7638 | Dexamethasone comp unit | Description: Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7639 | Dornase alfa non-comp unit | Description: Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
J7640 | Formoterol comp unit | Description: Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms |
J7641 | Flunisolide comp unit | Description: Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram |
J7642 | Glycopyrrolate comp con | Description: Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7643 | Glycopyrrolate comp unit | Description: Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7644 | Ipratropium bromide non-comp | Description: Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
J7645 | Ipratropium bromide comp | Description: Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7647 | Isoetharine comp con | Description: Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7648 | Isoetharine non-comp con | Description: Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
J7649 | Isoetharine non-comp unit | Description: Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
J7650 | Isoetharine comp unit | Description: Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7657 | Isoproterenol comp con | Description: Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7658 | Isoproterenol non-comp con | Description: Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
J7659 | Isoproterenol non-comp unit | Description: Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
J7660 | Isoproterenol comp unit | Description: Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7665 | Mannitol for inhaler | Description: Mannitol, administered through an inhaler, 5 mg |
J7667 | Metaproterenol comp con | Description: Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams |
J7668 | Metaproterenol non-comp con | Description: Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams |
J7669 | Metaproterenol non-comp unit | Description: Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
J7670 | Metaproterenol comp unit | Description: Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams |
J7674 | Methacholine chloride, neb | Description: Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg |
J7676 | Pentamidine comp unit dose | Description: Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg |
J7677 | Revefenacin inh non-com 1mcg | Description: Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram |
J7680 | Terbutaline sulf comp con | Description: Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7681 | Terbutaline sulf comp unit | Description: Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7682 | Tobramycin non-comp unit | Description: Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams |
J7683 | Triamcinolone comp con | Description: Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
J7684 | Triamcinolone comp unit | Description: Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
J7685 | Tobramycin comp unit | Description: Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams |
J7686 | Treprostinil, non-comp unit | Description: Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg |
J7699 | Inhalation solution for dme | Description: Noc drugs, inhalation solution administered through dme |
J7799 | Non-inhalation drug for dme | Description: Noc drugs, other than inhalation drugs, administered through dme |
J7999 | Compounded drug, noc | Description: Compounded drug, not otherwise classified |
J8498 | Antiemetic rectal/supp nos | Description: Antiemetic drug, rectal/suppository, not otherwise specified |
J8499 | Oral prescrip drug non chemo | Description: Prescription drug, oral, non chemotherapeutic, nos |
J8501 | Oral aprepitant | Description: Aprepitant, oral, 5 mg |
J8510 | Oral busulfan | Description: Busulfan; oral, 2 mg |
J8515 | Cabergoline, oral 0.25mg | Description: Cabergoline, oral, 0.25 mg |
J8520 | Capecitabine, oral, 150 mg | Description: Capecitabine, oral, 150 mg |
J8521 | Capecitabine, oral, 500 mg | Description: Capecitabine, oral, 500 mg |
J8522 | Capecitabine, oral, 50 mg | Description: Capecitabine, oral, 50 mg |
J8530 | Cyclophosphamide oral 25 mg | Description: Cyclophosphamide; oral, 25 mg |
J8540 | Oral dexamethasone | Description: Dexamethasone, oral, 0.25 mg |
J8541 | Oral, hemady, 0.25 mg | Description: Dexamethasone (hemady), oral, 0.25 mg |
J8560 | Etoposide oral 50 mg | Description: Etoposide; oral, 50 mg |
J8562 | Oral fludarabine phosphate | Description: Fludarabine phosphate, oral, 10 mg |
J8565 | Gefitinib oral | Description: Gefitinib, oral, 250 mg |
J8597 | Antiemetic drug oral nos | Description: Antiemetic drug, oral, not otherwise specified |
J8600 | Melphalan oral 2 mg | Description: Melphalan; oral, 2 mg |
J8610 | Methotrexate oral 2.5 mg | Description: Methotrexate; oral, 2.5 mg |
J8611 | Oral methotrexate (jylamvo) | Description: Methotrexate (jylamvo), oral, 2.5 mg |
J8612 | Oral methotrexate (xatmep) | Description: Methotrexate (xatmep), oral, 2.5 mg |
J8650 | Nabilone oral | Description: Nabilone, oral, 1 mg |
J8655 | Oral netupitant, palonosetro | Description: Netupitant 300 mg and palonosetron 0.5 mg, oral |
J8670 | Rolapitant, oral, 1mg | Description: Rolapitant, oral, 1 mg |
J8700 | Temozolomide | Description: Temozolomide, oral, 5 mg |
J8705 | Topotecan oral | Description: Topotecan, oral, 0.25 mg |
J8999 | Oral prescription drug chemo | Description: Prescription drug, oral, chemotherapeutic, nos |
J9000 | Doxorubicin hcl injection | Description: Injection, doxorubicin hydrochloride, 10 mg |
J9010 | Alemtuzumab injection | Description: Injection, alemtuzumab, 10 mg |
J9011 | Datopotamab deruxtecan, 1 mg | Description: Injection, datopotamab deruxtecan-dlnk, 1 mg |
J9015 | Aldesleukin injection | Description: Injection, aldesleukin, per single use vial |
J9017 | Arsenic trioxide injection | Description: Injection, arsenic trioxide, 1 mg |
J9019 | Erwinaze injection | Description: Injection, asparaginase (erwinaze), 1,000 iu |
J9020 | Asparaginase, nos | Description: Injection, asparaginase, not otherwise specified, 10,000 units |
J9021 | Inj, aspara, rylaze, 0.1 mg | Description: Injection, asparaginase, recombinant, (rylaze), 0.1 mg |
J9022 | Inj, atezolizumab,10 mg | Description: Injection, atezolizumab, 10 mg |
J9023 | Injection, avelumab, 10 mg | Description: Injection, avelumab, 10 mg |
J9024 | Inj atezolizumb 5mg hya-tqjs | Description: Injection, atezolizumab, 5 mg and hyaluronidase-tqjs |
J9025 | Azacitidine injection | Description: Injection, azacitidine, 1 mg |
J9026 | Inj, tarlatamab-dlle, 1 mg | Description: Injection, tarlatamab-dlle, 1 mg |
J9027 | Clofarabine injection | Description: Injection, clofarabine, 1 mg |
J9028 | Inj, nogapendekin pmln, 1mcg | Description: Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram |
J9029 | Instill adstiladrin, tx dose | Description: Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose |
J9030 | Bcg live intravesical 1mg | Description: Bcg live intravesical instillation, 1 mg |
J9031 | Bcg live intravesical vac | Description: Bcg (intravesical) per instillation |
J9032 | Injection, belinostat, 10mg | Description: Injection, belinostat, 10 mg |
J9033 | Inj, bendamustine hcl, 1mg | Description: Injection, bendamustine hydrochloride, 1 mg |
J9034 | Inj., bendeka 1 mg | Description: Injection, bendamustine hcl (bendeka), 1 mg |
J9035 | Bevacizumab injection | Description: Injection, bevacizumab, 10 mg |
J9036 | Inj. belrapzo/bendamustine | Description: Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg |
J9037 | Inj belantamab mafodot blmf | Description: Injection, belantamab mafodotin-blmf, 0.5 mg |
J9038 | Inj axatilimab-csfr 0.1 mg | Description: Injection, axatilimab-csfr, 0.1 mg |
J9039 | Injection, blinatumomab | Description: Injection, blinatumomab, 1 microgram |
J9040 | Bleomycin sulfate injection | Description: Injection, bleomycin sulfate, 15 units |
J9041 | Injection, bortezomib, 0.1mg | Description: Injection, bortezomib, 0.1 mg |
J9042 | Brentuximab vedotin inj | Description: Injection, brentuximab vedotin, 1 mg |
J9043 | Cabazitaxel injection | Description: Injection, cabazitaxel, 1 mg |
J9044 | Inj, bortezomib, nos, 0.1 mg | Description: Injection, bortezomib, not otherwise specified, 0.1 mg |
J9045 | Carboplatin injection | Description: Injection, carboplatin, 50 mg |
J9046 | Inj, bortezomib, dr. reddy's | Description: Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg |
J9047 | Injection, carfilzomib, 1 mg | Description: Injection, carfilzomib, 1 mg |
J9048 | Inj, bortezomib freseniuskab | Description: Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg |
J9049 | Inj, bortezomib, hospira | Description: Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg |
J9050 | Carmustine injection | Description: Injection, carmustine, 100 mg |
J9051 | Inj, bortezomib (maia) | Description: Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg |
J9052 | Inj, carmustine (accord) | Description: Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg |
J9054 | Inj bortezomib boruzu 0.1 mg | Description: Injection, bortezomib (boruzu), 0.1 mg |
J9055 | Cetuximab injection | Description: Injection, cetuximab, 10 mg |
J9056 | Inj, vivimusta, 1 mg | Description: Injection, bendamustine hydrochloride (vivimusta), 1 mg |
J9057 | Inj., copanlisib, 1 mg | Description: Injection, copanlisib, 1 mg |
J9058 | Inj apotex/bendamustine 1 mg | Description: Injection, bendamustine hydrochloride (apotex), 1 mg |
J9059 | Inj bendamustine, baxter 1mg | Description: Injection, bendamustine hydrochloride (baxter), 1 mg |
J9060 | Cisplatin 10 mg injection | Description: Injection, cisplatin, powder or solution, 10 mg |
J9061 | Inj, amivantamab-vmjw | Description: Injection, amivantamab-vmjw, 2 mg |
J9063 | Inj, elahere, 1 mg | Description: Injection, mirvetuximab soravtansine-gynx, 1 mg |
J9064 | Inj, cabazitaxel (sandoz) | Description: Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg |
J9065 | Inj cladribine per 1 mg | Description: Injection, cladribine, per 1 mg |
J9070 | Cyclophosphamide 100 mg inj | Description: Cyclophosphamide, 100 mg |
J9071 | Inj cyclophosphamd auromedic | Description: Injection, cyclophosphamide (auromedics), 5 mg |
J9072 | Inj cyclophos frindovyx 5 mg | Description: Injection, cyclophosphamide (frindovyx), 5 mg |
J9073 | Inj cyclophos dr reddys 5 mg | Description: Injection, cyclophosphamide (dr. reddy's), 5 mg |
J9074 | Inj, cyclophosphamd, sandoz | Description: Injection, cyclophosphamide (sandoz), 5 mg |
J9075 | Inj, cyclophosphamide, nos | Description: Injection, cyclophosphamide, not otherwise specified, 5 mg |
J9076 | Inj, cyclophos (baxter) 5mg | Description: Injection, cyclophosphamide (baxter), 5 mg |
J9098 | Cytarabine liposome inj | Description: Injection, cytarabine liposome, 10 mg |
J9100 | Cytarabine hcl 100 mg inj | Description: Injection, cytarabine, 100 mg |
J9118 | Inj. calaspargase pegol-mknl | Description: Injection, calaspargase pegol-mknl, 10 units |
J9119 | Inj., cemiplimab-rwlc, 1 mg | Description: Injection, cemiplimab-rwlc, 1 mg |
J9120 | Dactinomycin injection | Description: Injection, dactinomycin, 0.5 mg |
J9130 | Dacarbazine 100 mg inj | Description: Dacarbazine, 100 mg |
J9144 | Daratumumab, hyaluronidase | Description: Injection, daratumumab, 10 mg and hyaluronidase-fihj |
J9145 | Injection, daratumumab 10 mg | Description: Injection, daratumumab, 10 mg |
J9150 | Daunorubicin injection | Description: Injection, daunorubicin, 10 mg |
J9151 | Daunorubicin citrate inj | Description: Injection, daunorubicin citrate, liposomal formulation, 10 mg |
J9153 | Inj daunorubicin, cytarabine | Description: Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine |
J9155 | Degarelix injection | Description: Injection, degarelix, 1 mg |
J9160 | Denileukin diftitox inj | Description: Injection, denileukin diftitox, 300 micrograms |
J9161 | Inj denileuk difti-cxdl 1mcg | Description: Injection, denileukin diftitox-cxdl, 1 mcg |
J9165 | Diethylstilbestrol injection | Description: Injection, diethylstilbestrol diphosphate, 250 mg |
J9171 | Docetaxel injection | Description: Injection, docetaxel, 1 mg |
J9172 | Docetaxel (docivyx), 1 mg | Description: Injection, docetaxel (docivyx), 1 mg |
J9173 | Inj., durvalumab, 10 mg | Description: Injection, durvalumab, 10 mg |
J9174 | Inj, docetaxel (beizray) 1mg | Description: Injection, docetaxel (beizray), 1 mg |
J9175 | Elliotts b solution per ml | Description: Injection, elliotts' b solution, 1 ml |
J9176 | Injection, elotuzumab, 1mg | Description: Injection, elotuzumab, 1 mg |
J9177 | Inj enfort vedo-ejfv 0.25mg | Description: Injection, enfortumab vedotin-ejfv, 0.25 mg |
J9178 | Inj, epirubicin hcl, 2 mg | Description: Injection, epirubicin hcl, 2 mg |
J9179 | Eribulin mesylate injection | Description: Injection, eribulin mesylate, 0.1 mg |
J9181 | Etoposide injection | Description: Injection, etoposide, 10 mg |
J9185 | Fludarabine phosphate inj | Description: Injection, fludarabine phosphate, 50 mg |
J9190 | Fluorouracil injection | Description: Injection, fluorouracil, 500 mg |
J9196 | Inj gemcitabine hcl (accord) | Description: Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg |
J9198 | Inj. infugem, 100 mg | Description: Injection, gemcitabine hydrochloride, (infugem), 100 mg |
J9199 | Injection, infugem, 200 mg | Description: Injection, gemcitabine hydrochloride (infugem), 200 mg |
J9200 | Floxuridine injection | Description: Injection, floxuridine, 500 mg |
J9201 | In gemcitabine hcl nos 200mg | Description: Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
J9202 | Goserelin acetate implant | Description: Goserelin acetate implant, per 3.6 mg |
J9203 | Gemtuzumab ozogamicin 0.1 mg | Description: Injection, gemtuzumab ozogamicin, 0.1 mg |
J9204 | Inj mogamulizumab-kpkc, 1 mg | Description: Injection, mogamulizumab-kpkc, 1 mg |
J9205 | Inj irinotecan liposome 1 mg | Description: Injection, irinotecan liposome, 1 mg |
J9206 | Irinotecan injection | Description: Injection, irinotecan, 20 mg |
J9207 | Ixabepilone injection | Description: Injection, ixabepilone, 1 mg |
J9208 | Ifosfamide injection | Description: Injection, ifosfamide, 1 gram |
J9209 | Mesna injection | Description: Injection, mesna, 200 mg |
J9210 | Inj., emapalumab-lzsg, 1 mg | Description: Injection, emapalumab-lzsg, 1 mg |
J9211 | Idarubicin hcl injection | Description: Injection, idarubicin hydrochloride, 5 mg |
J9212 | Interferon alfacon-1 inj | Description: Injection, interferon alfacon-1, recombinant, 1 microgram |
J9213 | Interferon alfa-2a inj | Description: Injection, interferon, alfa-2a, recombinant, 3 million units |
J9214 | Interferon alfa-2b inj | Description: Injection, interferon, alfa-2b, recombinant, 1 million units |
J9215 | Interferon alfa-n3 inj | Description: Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu |
J9216 | Interferon gamma 1-b inj | Description: Injection, interferon, gamma 1-b, 3 million units |
J9217 | Leuprolide acetate suspnsion | Description: Leuprolide acetate (for depot suspension), 7.5 mg |
J9218 | Leuprolide acetate injeciton | Description: Leuprolide acetate, per 1 mg |
J9219 | Leuprolide acetate implant | Description: Leuprolide acetate implant, 65 mg |
J9220 | Indigotindisulfonate sod 1mg | Description: Injection, indigotindisulfonate sodium, 1 mg |
J9223 | Inj. lurbinectedin, 0.1 mg | Description: Injection, lurbinectedin, 0.1 mg |
J9225 | Vantas implant | Description: Histrelin implant (vantas), 50 mg |
J9226 | Supprelin la implant | Description: Histrelin implant (supprelin la), 50 mg |
J9227 | Inj. isatuximab-irfc 10 mg | Description: Injection, isatuximab-irfc, 10 mg |
J9228 | Ipilimumab injection | Description: Injection, ipilimumab, 1 mg |
J9229 | Inj inotuzumab ozogam 0.1 mg | Description: Injection, inotuzumab ozogamicin, 0.1 mg |
J9230 | Mechlorethamine hcl inj | Description: Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg |
J9245 | Inj melpha hydroch nos 50 mg | Description: Injection, melphalan hydrochloride, not otherwise specified, 50 mg |
J9246 | Inj., evomela, 1 mg | Description: Injection, melphalan (evomela), 1 mg |
J9247 | Inj, melphalan flufenami 1mg | Description: Injection, melphalan flufenamide, 1mg |
J9248 | Inj melphalan (hepzato) 1 mg | Description: Injection, melphalan (hepzato), 1 mg |
J9249 | Inj, melphalan (apotex) 1 mg | Description: Injection, melphalan (apotex), 1 mg |
J9250 | Methotrexate sodium inj | Description: Methotrexate sodium, 5 mg |
J9255 | Inj, methotrexate (accord) | Description: Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg |
J9258 | Paclitaxel (teva) | Description: Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg |
J9259 | Paclitaxel (american regent) | Description: Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg |
J9260 | Inj methotrexate sodium 50mg | Description: Injection, methotrexate sodium, 50 mg |
J9261 | Nelarabine injection | Description: Injection, nelarabine, 50 mg |
J9262 | Inj, omacetaxine mep, 0.01mg | Description: Injection, omacetaxine mepesuccinate, 0.01 mg |
J9263 | Oxaliplatin | Description: Injection, oxaliplatin, 0.5 mg |
J9264 | Paclitaxel protein bound | Description: Injection, paclitaxel protein-bound particles, 1 mg |
J9265 | Paclitaxel injection | Description: Injection, paclitaxel, 30 mg |
J9266 | Pegaspargase injection | Description: Injection, pegaspargase, per single dose vial |
J9267 | Paclitaxel injection | Description: Injection, paclitaxel, 1 mg |
J9268 | Pentostatin injection | Description: Injection, pentostatin, 10 mg |
J9269 | Inj. tagraxofusp-erzs 10 mcg | Description: Injection, tagraxofusp-erzs, 10 micrograms |
J9270 | Plicamycin (mithramycin) inj | Description: Injection, plicamycin, 2.5 mg |
J9271 | Inj pembrolizumab | Description: Injection, pembrolizumab, 1 mg |
J9272 | Inj, dostarlimab-gxly, 10 mg | Description: Injection, dostarlimab-gxly, 10 mg |
J9273 | Inj tisotu vedotin-tftv, 1mg | Description: Injection, tisotumab vedotin-tftv, 1 mg |
J9274 | Inj, tebentafusp-tebn, 1 mcg | Description: Injection, tebentafusp-tebn, 1 microgram |
J9275 | Inj cosibelimab-ipdl, 2 mg | Description: Injection, cosibelimab-ipdl, 2 mg |
J9276 | Inj zanidatamab-hrii, 2 mg | Description: Injection, zanidatamab-hrii, 2 mg |
J9280 | Mitomycin injection | Description: Injection, mitomycin, 5 mg |
J9281 | Mitomycin instillation | Description: Mitomycin pyelocalyceal instillation, 1 mg |
J9285 | Inj, olaratumab, 10 mg | Description: Injection, olaratumab, 10 mg |
J9286 | Inj glofitamab gxbm, 2.5 mg | Description: Injection, glofitamab-gxbm, 2.5 mg |
J9289 | Inj nivolumab 2 mg hyaluron | Description: Injection, nivolumab, 2 mg and hyaluronidase-nvhy |
J9292 | Inj, pemetrexed dipotassium | Description: Injection, pemetrexed dipotassium, 10 mg |
J9293 | Mitoxantrone hydrochl / 5 mg | Description: Injection, mitoxantrone hydrochloride, per 5 mg |
J9294 | Inj pemetrexed, hospira 10mg | Description: Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg |
J9295 | Injection, necitumumab, 1 mg | Description: Injection, necitumumab, 1 mg |
J9296 | Inj pemetrexed (accord) 10mg | Description: Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg |
J9297 | Inj pemetrexed (sandoz) 10mg | Description: Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg |
J9298 | Inj nivol relatlimab 3mg/1mg | Description: Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg |
J9299 | Injection, nivolumab | Description: Injection, nivolumab, 1 mg |
J9300 | Gemtuzumab ozogamicin inj | Description: Injection, gemtuzumab ozogamicin, 5 mg |
J9301 | Obinutuzumab inj | Description: Injection, obinutuzumab, 10 mg |
J9302 | Ofatumumab injection | Description: Injection, ofatumumab, 10 mg |
J9303 | Panitumumab injection | Description: Injection, panitumumab, 10 mg |
J9304 | Inj. pemetrexed, 10 mg | Description: Injection, pemetrexed (pemfexy), 10 mg |
J9305 | Inj. pemetrexed nos 10mg | Description: Injection, pemetrexed, not otherwise specified, 10 mg |
J9306 | Injection, pertuzumab, 1 mg | Description: Injection, pertuzumab, 1 mg |
J9307 | Pralatrexate injection | Description: Injection, pralatrexate, 1 mg |
J9308 | Injection, ramucirumab | Description: Injection, ramucirumab, 5 mg |
J9309 | Inj, polatuzumab vedotin 1mg | Description: Injection, polatuzumab vedotin-piiq, 1 mg |
J9310 | Rituximab injection | Description: Injection, rituximab, 100 mg |
J9311 | Inj rituximab, hyaluronidase | Description: Injection, rituximab 10 mg and hyaluronidase |
J9312 | Inj., rituximab, 10 mg | Description: Injection, rituximab, 10 mg |
J9313 | Inj., lumoxiti, 0.01 mg | Description: Injection, moxetumomab pasudotox-tdfk, 0.01 mg |
J9314 | Inj pemetrexed (teva) 10mg | Description: Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg |
J9315 | Romidepsin injection | Description: Injection, romidepsin, 1 mg |
J9316 | Pertuzu, trastuzu, 10 mg | Description: Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg |
J9317 | Sacituzumab govitecan-hziy | Description: Injection, sacituzumab govitecan-hziy, 2.5 mg |
J9318 | Inj romidepsin non-lyo 0.1mg | Description: Injection, romidepsin, non-lyophilized, 0.1 mg |
J9319 | Inj romidepsin lyophil 0.1mg | Description: Injection, romidepsin, lyophilized, 0.1 mg |
J9320 | Streptozocin injection | Description: Injection, streptozocin, 1 gram |
J9321 | Inj epcoritamab-bysp 0.16 mg | Description: Injection, epcoritamab-bysp, 0.16 mg |
J9322 | Inj pemetrexed (bluepoint) | Description: Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg |
J9323 | Inj pemetrexed ditromethamin | Description: Injection, pemetrexed ditromethamine, 10 mg |
J9324 | Inj, pemrydi rtu, 10 mg | Description: Injection, pemetrexed (pemrydi rtu), 10 mg |
J9325 | Inj talimogene laherparepvec | Description: Injection, talimogene laherparepvec, per 1 million plaque forming units |
J9328 | Temozolomide injection | Description: Injection, temozolomide, 1 mg |
J9329 | Inj, tislelizumab-jsgr | Description: Injection, tislelizumab-jsgr, 1mg |
J9330 | Temsirolimus injection | Description: Injection, temsirolimus, 1 mg |
J9331 | Inj sirolimus prot part 1 mg | Description: Injection, sirolimus protein-bound particles, 1 mg |
J9332 | Inj efgartigimod 2mg | Description: Injection, efgartigimod alfa-fcab, 2mg |
J9333 | Inj rozanolixizum-noli 1 mg | Description: Injection, rozanolixizumab-noli, 1 mg |
J9334 | Inj efgart-alfa 2mg hya-qvfc | Description: Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc |
J9340 | Thiotepa injection | Description: Injection, thiotepa, 15 mg |
J9341 | Inj thiotepa (tepylute) 1 mg | Description: Injection, thiotepa (tepylute), 1 mg |
J9342 | Inj thiotepa nos 1 mg | Description: Injection, thiotepa, not otherwise specified, 1 mg |
J9345 | Inj, retifanlimab-dlwr, 1 mg | Description: Injection, retifanlimab-dlwr, 1 mg |
J9347 | Inj, tremelimumab-actl, 1 mg | Description: Injection, tremelimumab-actl, 1 mg |
J9348 | Inj. naxitamab-gqgk, 1 mg | Description: Injection, naxitamab-gqgk, 1 mg |
J9349 | Inj., tafasitamab-cxix | Description: Injection, tafasitamab-cxix, 2 mg |
J9350 | Inj mosunetuzumab-axgb, 1 mg | Description: Injection, mosunetuzumab-axgb, 1 mg |
J9351 | Topotecan injection | Description: Injection, topotecan, 0.1 mg |
J9352 | Injection trabectedin 0.1mg | Description: Injection, trabectedin, 0.1 mg |
J9353 | Inj. margetuximab-cmkb, 5 mg | Description: Injection, margetuximab-cmkb, 5 mg |
J9354 | Inj, ado-trastuzumab emt 1mg | Description: Injection, ado-trastuzumab emtansine, 1 mg |
J9355 | Inj trastuzumab excl biosimi | Description: Injection, trastuzumab, excludes biosimilar, 10 mg |
J9356 | Inj. herceptin hylecta, 10mg | Description: Injection, trastuzumab, 10 mg and hyaluronidase-oysk |
J9357 | Valrubicin injection | Description: Injection, valrubicin, intravesical, 200 mg |
J9358 | Inj fam-trastu deru-nxki 1mg | Description: Injection, fam-trastuzumab deruxtecan-nxki, 1 mg |
J9359 | Inj lon tesirin-lpyl 0.075mg | Description: Injection, loncastuximab tesirine-lpyl, 0.075 mg |
J9360 | Vinblastine sulfate inj | Description: Injection, vinblastine sulfate, 1 mg |
J9361 | Inj, efbemalenograstim alfa- | Description: Injection, efbemalenograstim alfa-vuxw, 0.5 mg |
J9370 | Vincristine sulfate 1 mg inj | Description: Vincristine sulfate, 1 mg |
J9371 | Inj, vincristine sul lip 1mg | Description: Injection, vincristine sulfate liposome, 1 mg |
J9376 | Inj pozelimab-bbfg, 1 mg | Description: Injection, pozelimab-bbfg, 1 mg |
J9380 | Inj teclistamab cqyv 0.5 mg | Description: Injection, teclistamab-cqyv, 0.5 mg |
J9381 | Inj teplizumab mzwv 5 mcg | Description: Injection, teplizumab-mzwv, 5 mcg |
J9382 | Inj zenocutuzumab-zbco 1 mg | Description: Injection, zenocutuzumab-zbco, 1 mg |
J9390 | Vinorelbine tartrate inj | Description: Injection, vinorelbine tartrate, 10 mg |
J9393 | Inj, fulvestrant (teva) | Description: Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg |
J9394 | Inj, fulvestrant (fresenius) | Description: Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg |
J9395 | Injection, fulvestrant | Description: Injection, fulvestrant, 25 mg |
J9400 | Inj, ziv-aflibercept, 1mg | Description: Injection, ziv-aflibercept, 1 mg |
J9600 | Porfimer sodium injection | Description: Injection, porfimer sodium, 75 mg |
J9999 | Chemotherapy drug | Description: Not otherwise classified, antineoplastic drugs |
K0001 | Standard wheelchair | Description: Standard wheelchair |
K0002 | Stnd hemi (low seat) whlchr | Description: Standard hemi (low seat) wheelchair |
K0003 | Lightweight wheelchair | Description: Lightweight wheelchair |
K0004 | High strength ltwt whlchr | Description: High strength, lightweight wheelchair |
K0005 | Ultralightweight wheelchair | Description: Ultralightweight wheelchair |
K0006 | Heavy duty wheelchair | Description: Heavy duty wheelchair |
K0007 | Extra heavy duty wheelchair | Description: Extra heavy duty wheelchair |
K0008 | Cstm manual wheelchair/base | Description: Custom manual wheelchair/base |
K0009 | Other manual wheelchair/base | Description: Other manual wheelchair/base |
K0010 | Stnd wt frame power whlchr | Description: Standard - weight frame motorized/power wheelchair |
K0011 | Stnd wt pwr whlchr w control | Description: Standard - weight frame motorized/power wheelchair with programmable control parameters for speed adjustment, tremor dampening, acceleration control and braking |
K0012 | Ltwt portbl power whlchr | Description: Lightweight portable motorized/power wheelchair |
K0013 | Custom power whlchr base | Description: Custom motorized/power wheelchair base |
K0014 | Other power whlchr base | Description: Other motorized/power wheelchair base |
K0015 | Detach non-adj ht armrst rep | Description: Detachable, non-adjustable height armrest, replacement only, each |
K0017 | Detach adjust armrest base | Description: Detachable, adjustable height armrest, base, replacement only, each |
K0018 | Detach adjust armrst upper | Description: Detachable, adjustable height armrest, upper portion, replacement only, each |
K0019 | Arm pad repl, each | Description: Arm pad, replacement only, each |
K0020 | Fixed adjust armrest pair | Description: Fixed, adjustable height armrest, pair |
K0037 | Hi mount flip-up footrest ea | Description: High mount flip-up footrest, each |
K0038 | Leg strap each | Description: Leg strap, each |
K0039 | Leg strap h style each | Description: Leg strap, h style, each |
K0040 | Adjustable angle footplate | Description: Adjustable angle footplate, each |
K0041 | Large size footplate each | Description: Large size footplate, each |
K0042 | Standard size ftplate rep ea | Description: Standard size footplate, replacement only, each |
K0043 | Ftrst lowr exten tube rep ea | Description: Footrest, lower extension tube, replacement only, each |
K0044 | Ftrst upr hanger brac rep ea | Description: Footrest, upper hanger bracket, replacement only, each |
K0045 | Ftrst compl assembly repl ea | Description: Footrest, complete assembly, replacement only, each |
K0046 | Elev lgrst lwr exten repl ea | Description: Elevating legrest, lower extension tube, replacement only, each |
K0047 | Elev legrst upr hangr rep ea | Description: Elevating legrest, upper hanger bracket, replacement only, each |
K0050 | Ratchet assembly replacement | Description: Ratchet assembly, replacement only |
K0051 | Cam rel asm ft/legrst rep ea | Description: Cam release assembly, footrest or legrest, replacement only, each |
K0052 | Swingaway detach ftrest repl | Description: Swingaway, detachable footrests, replacement only, each |
K0053 | Elevate footrest articulate | Description: Elevating footrests, articulating (telescoping), each |
K0056 | Seat ht <17 or >=21 ltwt wc | Description: Seat height less than 17' or equal to or greater than 21' for a high strength, lightweight, or ultralightweight wheelchair |
K0065 | Spoke protectors | Description: Spoke protectors, each |
K0069 | Rr whl compl sol tire rep ea | Description: Rear wheel assembly, complete, with solid tire, spokes or molded, replacement only, each |
K0070 | Rr whl compl pne tire rep ea | Description: Rear wheel assembly, complete, with pneumatic tire, spokes or molded, replacement only, each |
K0071 | Fr cstr comp pne tire rep ea | Description: Front caster assembly, complete, with pneumatic tire, replacement only, each |
K0072 | Fr cstr semi-pne tire rep ea | Description: Front caster assembly, complete, with semi-pneumatic tire, replacement only, each |
K0073 | Caster pin lock each | Description: Caster pin lock, each |
K0077 | Fr cstr asmb sol tire rep ea | Description: Front caster assembly, complete, with solid tire, replacement only, each |
K0098 | Drive belt for pwc, repl | Description: Drive belt for power wheelchair, replacement only |